These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29512102)

  • 21. Bioresorbable Vascular Scaffold Technology Benefits From Healthy Skepticism.
    Cassese S; Kastrati A
    J Am Coll Cardiol; 2016 Mar; 67(8):932-935. PubMed ID: 26916482
    [No Abstract]   [Full Text] [Related]  

  • 22. Early Collapse of a Magnesium Bioresorbable Scaffold.
    Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.
    Puricel S; Cuculi F; Weissner M; Schmermund A; Jamshidi P; Nyffenegger T; Binder H; Eggebrecht H; Münzel T; Cook S; Gori T
    J Am Coll Cardiol; 2016 Mar; 67(8):921-931. PubMed ID: 26916481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.
    Karanasos A; Van Mieghem N; van Ditzhuijzen N; Felix C; Daemen J; Autar A; Onuma Y; Kurata M; Diletti R; Valgimigli M; Kauer F; van Beusekom H; de Jaegere P; Zijlstra F; van Geuns RJ; Regar E
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventional cardiology: Increased risk of stent thrombosis with bioresorbable scaffolds.
    Lim GB
    Nat Rev Cardiol; 2017 Jun; 14(6):318. PubMed ID: 28406183
    [No Abstract]   [Full Text] [Related]  

  • 26. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very Late Bioresorbable Scaffold Thrombosis Caused by Intraluminal Scaffold Dismantling.
    Chan CY; Wu EB; Yan BP
    JACC Cardiovasc Interv; 2016 Sep; 9(17):1844-7. PubMed ID: 27544008
    [No Abstract]   [Full Text] [Related]  

  • 28. Bioresorbable Vascular Scaffolds for Coronary Revascularization.
    Kereiakes DJ; Onuma Y; Serruys PW; Stone GW
    Circulation; 2016 Jul; 134(2):168-82. PubMed ID: 27400899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very late thrombosis observed on optical coherence tomography 22 months after the implantation of a polymer-based bioresorbable vascular scaffold.
    Sato T; Abdel-Wahab M; Richardt G
    Eur Heart J; 2015 May; 36(20):1273. PubMed ID: 25736253
    [No Abstract]   [Full Text] [Related]  

  • 30. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
    Yahagi K; Virmani R; Kesavamoorthy B
    Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
    Pichette M; Chevalier F; Généreux P
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary Artery Aneurysm With Thrombosis After Implantation of a Bioresorbable Coronary Artery Scaffold.
    Hemetsberger R; Gürocak O; Soud M; Garcia-Garcia HM; Weber-Albers J; Nef H; Möllmann H
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e173-e174. PubMed ID: 28935086
    [No Abstract]   [Full Text] [Related]  

  • 33. Is There Light at the End of the Thin-Strut Tunnel?: In Vitro Insights on Strut Thickness Impact on Thrombogenicity in Bioresorbable Stents or Scaffolds.
    Lu S; Ng J; Ang H; Paradies V; Wong PE; Al-Lamee R; Al-Lamee K; Bullett N; Ahmed N; Joner M; Foin N
    JACC Cardiovasc Interv; 2018 Apr; 11(7):714-716. PubMed ID: 29622153
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis.
    Mangiameli A; Fajadet J; Dumonteil N
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):1-3. PubMed ID: 27562758
    [No Abstract]   [Full Text] [Related]  

  • 35. Bioresorbable vascular scaffold strut disruption after crossing with an optical coherence tomography imaging catheter.
    Sato K; Panoulas VF; Naganuma T; Miyazaki T; Latib A; Colombo A
    Int J Cardiol; 2014 Jul; 174(3):e116-9. PubMed ID: 24814543
    [No Abstract]   [Full Text] [Related]  

  • 36. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
    Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute stent thrombosis of a bioresorbable vascular scaffold implanted for ST-segment elevation myocardial infarction.
    Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
    Int J Cardiol; 2014 Jun; 174(2):e72-4. PubMed ID: 24784914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.